Bictegravir
Bictegravir
Bictegravir (pronounced as bihk-TEG-rah-veer) is an antiretroviral medication used in the treatment of HIV/AIDS. It is a type of Integrase inhibitor, which works by blocking the action of an enzyme called integrase that the HIV virus needs to multiply.
Etymology
The name "Bictegravir" is derived from its chemical structure. The "bi" refers to the two fluorine atoms in the compound, "cte" refers to the cyano and thioether groups, and "gravir" is a common suffix for integrase inhibitors.
Usage
Bictegravir is used in combination with other antiretroviral drugs, such as Emtricitabine and Tenofovir alafenamide, to treat HIV. This combination is sold under the brand name Biktarvy.
Side Effects
Common side effects of Bictegravir include nausea, diarrhea, and headache. Serious side effects may include liver problems and kidney problems.
Related Terms
External links
- Medical encyclopedia article on Bictegravir
- Wikipedia's article - Bictegravir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski